drugset / Trial / NCT00135759

Addition of Naltrexone to Methadone Taper

NCT00135759

Phase 2 Completed 174 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupDouble-blindTreatment

Summary

There is a continuing search for more effective opiate detoxification treatments. This study's purpose is to investigate the effects of adding very low doses of naltrexone to a methadone tapering treatment in opioid dependent individuals.

Timeline

Start
2005-04
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 0.125 mg
Subject Naltrexone Small molecule 0.25 mg

Indications